Eagle Pharmaceuticals Inc (OTCPK:EGRX)
$ 0.8 0.3 (60%) Market Cap: 10.37 Mil Enterprise Value: 62.74 Mil PE Ratio: 0.88 PB Ratio: 0 GF Score: 60/100

Eagle Pharmaceuticals Inc at Morgan Stanley Healthcare Conference Transcript

Sep 11, 2019 / 01:20PM GMT
Release Date Price: $59.98 (+3.43%)
Unidentified Analyst

Good morning, everyone. Thank you for being here. I'm pleased to introduce Eagle Pharmaceuticals this morning. From the company, we have Scott Tarriff, the CEO; as well as Pete Meyers, the CFO. So thank you both for joining us this morning.

Scott L. Tarriff
Eagle Pharmaceuticals, Inc. - CEO & Director

Thank you for having us.

Questions & Answers

Unidentified Analyst

Perhaps, firstly, we can start with an update on the business overall. Obviously, a number of important milestones and outcomes for you in the first half of the year, so it would be great to get an update from you guys.

Scott L. Tarriff
Eagle Pharmaceuticals, Inc. - CEO & Director

Yes. I would be pleased. Thank you, again, for having us here. Thanks for everybody who are attending. I think as you look to the future of Eagle, it's really a story about our pipeline, where we're a profitable company, we have a lot of cash, we don't have any debt. We don't have a number of the concerns

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot